“Last weeks ‘Girl Rising’ showing to kick off Girls Who Code held at UC Davis was inspriring. One of the girls’ stories really struck me. After 2010’s Haitian earthquake destroys litttle Wadley’s home and school, the small but never daunted girl finds herself climbing out of the rubble in search of a shanty school where she can continue her education. When turned away, Wadley’s proclamation, ‘I will come back every day until I can stay,’ left not just a smile on my face, but a irrepressible faith that this spirited young girl from Haiti would fight harder and harder with passing time for her education. All I could think was, ‘Get it, girl!'” —Megan
Riding on the wave of success of the innaugural event that took place in New York City last October, we at Global HealthShare are honored to be teaming up with Intel this summer to bring Girls Who Code to the West Coast. If you or a girl you know is interested in applying, check out the GWC website: http://www.girlswhocode.com/applynow.
Girl Rising, http://girlrising.com/
Girls Who Code, http://www.girlswhocode.com/
CSIR is one of the leading scientific and technology research, development, and implementation organizations in Africa. GHS and CSIR will collaborate on 1) the development of plant-based rabies vaccines and anti-rabies immunoglobulins and 2) the design, construction, and operation of a rabies vaccine facility in Bangladesh.
RKMVU, located in Belur Math, Howrah, India, is an internationally recognized university administered by the Ramakrishna Mission. The university has served the country in many areas, including education, health, relief and rehabilitation, and propagation of Indian cultural heritage for over a century. GHS and RKMVU will work together to improve nutritional health and food security in rural, low-income regions that are adversely impacted by climate change and seasonal disasters. The partnership will also promote exchange and bidirectional learning to improve global health, education, and outreach efforts.
iOWH is a non-profit drug development company that is headquartered in San Francisco and New Delhi. Its mission is to discover, develop, and deliver safe, effective, and affordable new treatments for neglected diseases afflicting children in the developing world. GHS and iOWH will collaborate on validating the safety and efficacy of novel plant-based rabies vaccines and anti-rabies immunoglobulins. iOWH will also provide valuable expertise and facilities for human clinical trials.
On November 23, 2010, the Center of Excellence for Nutritional Genomics signed two separate Memoranda of Understanding (MOU) with the Disease Control Unit (DCU) under Directorate General of Health Services (DGHS) of the Ministry of Health and Family Welfare of the Government of the Peoples’ Republic of Bangladesh and the Institute of Allergy and Clinical Immunology of Bangladesh (IACIB) for the trials and collaborative work on rabies and other projects.
ICDDR,B, is a world-class international health research institution that is dedicated to saving lives through research, treatment, and education in fields ranging from neonatal care to HIV/AIDS. This partnership provides GHS with access to talented researchers and physicians skilled in conducting human trials in the treatment of acute malnutrition and diarrheal disease.
TSI is a private venture company established to promote international industry-university collaboration and spin-outs into independent, self-sufficient companies. TSI’s role is to facilitate the commercialization of the fruits of academic research. GHS and TSI will work together to secure funding for GHS projects and identify private-sector partners to assist in the implementation of GHS health solutions.